H. -A. Horst

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil et al. · Leukemia · 2016 · 283 citations

Medicine, Genetics, Molecular Genetics +16

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Wolfgang Bethge, Jolanta Dengler, M Bornhäuser et al. · Leukemia · 2012 · 230 citations

Medicine, Hematology, Oncology +14

Lymphoreticular infiltrates in invasive ductal breast cancer

H.-P. Horny, H. -A. Horst · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1986 · 30 citations

Medicine, Immunology, Oncology +14

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Marie Luise Hütter‐Krönke, Axel Benner, Konstanze Döhner et al. · Haematologica · 2016 · 23 citations · Full text

Medicine, Hematology, Oncology +17

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group

Nikolaus Jahn, Mridul Agrawal, Lars Bullinger et al. · Leukemia · 2017 · 20 citations

Life Sciences, Genetics, Hematology +15